SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

Peer Review reports

Original Submission
21 Oct 2019	Submitted	Original manuscript
17 Nov 2019	Author responded	Author comments - Michael Jameson
Resubmission - Version 2
17 Nov 2019	Submitted	Manuscript version 2
23 Nov 2019	Author responded	Author comments - Michael Jameson
Resubmission - Version 3
23 Nov 2019	Submitted	Manuscript version 3
Publishing
26 Nov 2019	Editorially accepted
17 Dec 2019	Article published	10.1186/s12885-019-6405-7

Back to article page